VALIDATION IMAGES
Lane 1: Hela Cells; Lane 2: PC-12 Cells; Lane 3: NIH-3T3 Cells; Lane 4: Rat Liver; Lane 5: A431 Cells; Lane 6: HepG2 Cells; Probed with ACTN4 (6A1) Monoclonal Antibody (bsm-54157R) at 1:500 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
IF(ICC) staining with ACTN4 (6A1) Monoclonal Antibody (bsm-54157R) at 1:100 in A549 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with ACTN4 (6A1) Monoclonal Antibody (bsm-54157R) at 1:100 in Hela cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with ACTN4 (6A1) Monoclonal Antibody (bsm-54157R) at 1:100 in LOVO cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
Paraformaldehyde-fixed and paraffin-embedded Human Colon Cancer tissue incubated with ACTN4 (6A1) Monoclonal Antibody (bsm-54157R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Mouse Colon tissue incubated with ACTN4 (6A1) Monoclonal Antibody (bsm-54157R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Flow cytometric analysis of A549 cells with ACTN4 (6A1) Monoclonal Antibody (bsm-54157R) at 1:100 dilution (red) compared with an unlabeled control (cells without incubation with primary antibody; black).